The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Parkes Weber syndrome, vein of Galen aneurysmal malformation, and other fast-flow vascular anomalies are caused byRASA1 mutations
Open accessAbstract
Capillary malformation-arteriovenous malformation (CM-AVM) is a newly recognized autosomal dominant disorder, caused by mutations in the RASA1 gene in six families. Here we report 42 novel RASA1 mutations and the associated phenotype in 44 families. The penetrance and de novo occurrence were high. All affected individuals presented multifocal capillary malformations (CMs), which represent the hallmark of the disorder. Importantly, one-third had fast-flow vascular lesions. Among them, we observed severe intracranial AVMs, including vein of Galen aneurysmal malformation, which were symptomatic at birth or during infancy, extracranial AVM of the face and extremities, and Parkes Weber syndrome (PKWS), previously considered sporadic and nongenetic. These fast-flow lesions can be differed from the other two genetic AVMs seen in hereditary hemorrhagic telangiectasia (HHT) and in phosphatase and tensin homolog (PTEN) hamartomatous tumor syndrome. Finally, some CM-AVM patients had neural tumors reminiscent of neurofibromatosis type 1 or 2. This is the first extensive study on the phenotypes associated with RASA1 mutations, and unravels their wide heterogeneity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Eerola, I., Boon, L. M., Mulliken, J. B., Burrows, P. E., Dompmartin, A., Watanabe, S., Vanwijck, R., & Vikkula, M. (2003) · The American Journal of Human Genetics · doi:10.1086/379793 · Cited by 756
Self-citationHapple, R. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)80249-9 · Cited by 552
Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease
Abdalla, S. A., & Letarte, M. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.030833 · Cited by 381
Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein
Henkemeyer, M., Rossi, D. J., Holmyard, D. P., Puri, M. C., Mbamalu, G., Harpal, K., Shih, T. S., Jacks, T., & Pawson, T. (1995) · Nature · doi:10.1038/377695a0 · Cited by 366
Brouillard, P., Boon, L. M., Mulliken, J. B., Enjolras, O., Ghassibé, M., Warman, M. L., Tan, O. T., Olsen, B. R., & Vikkula, M. (2002) · The American Journal of Human Genetics · doi:10.1086/339492 · Cited by 342
Self-citationTan, W.-H., Baris, H. N., Burrows, P. E., Robson, C. D., Alomari, A. I., Mulliken, J. B., Fishman, S. J., & Irons, M. B. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2007.048934 · Cited by 304
Self-citationZhou, X.-P. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.5.765 · Cited by 215
Gault, J., Shenkar, R., Recksiek, P., & Awad, I. A. (2005) · Stroke · doi:10.1161/01.str.0000157586.20479.fd · Cited by 157
Multiple roles for neurofibromin in skeletal development and growth
Kolanczyk, M., Kossler, N., Kühnisch, J., Lavitas, L.-M., Stricker, S., Wilkening, U., Manjubala, I., Fratzl, P., Spörle, R., Herrmann, B. G., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm032 · Cited by 149
Role of P120 Ras-Gap in Directed Cell Movement
Kulkarni, S., Gish, G. D., van der Geer, P., Henkemeyer, M. J., & Pawson, T. J. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.149.2.457 · Cited by 149
Morgan, T. K., McDonald, J., Anderson, C. G., Ismail, M., Miller, F. J., Mao, R., Madan, A., Barnes, P. D., Hudgins, L., & Manning, M. A. (2002) · PEDIATRICS · doi:10.1542/peds.109.1.e12 · Cited by 138
Friedman, E., Gejman, P. V., Martin, G. A., & McCormick, F. P. (1993) · Nature Genetics · doi:10.1038/ng1193-242 · Cited by 61
Nf1 haploinsufficiency augments angiogenesis
Wu, M., Wallace, M. R., & Muir, D. (2005) · Oncogene · doi:10.1038/sj.onc.1209264 · Cited by 55
Ras GTPase-activating Protein Binds to Akt and Is Required for Its Activation
Yue, Y., Lypowy, J., Hedhli, N., & Abdellatif, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312308200 · Cited by 51
Cited by
Ras in Cancer and Developmental Diseases
Fernandez-Medarde, A., & Santos, E. (2011) · Genes & Cancer · doi:10.1177/1947601911411084 · Cited by 897
Rauen, K. A. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153523 · Cited by 879
Editor's Choice – Management of Chronic Venous Disease
Wittens, C., Davies, A. H., Bækgaard, N., Broholm, R., Cavezzi, A., Chastanet, S., de Wolf, M., Eggen, C., Giannoukas, A., Gohel, M., et al. (2015) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2015.02.007 · Cited by 852
Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular Anomalies
Adams, D. M., Trenor, C. C., Hammill, A. M., Vinks, A. A., Patel, M. N., Chaudry, G., Wentzel, M. S., Mobberley-Schuman, P. S., Campbell, L. M., Brookbank, C., et al. (2016) · Pediatrics · doi:10.1542/peds.2015-3257 · Cited by 844
Dejana, E., Tournier-Lasserve, E., & Weinstein, B. M. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.004 · Cited by 788
Metadata
- Authors
- Revencu, N., Boon, L. M., Mulliken, J. B., Enjolras, O., Cordisco, M. R., Burrows, P. E., Clapuyt, P., Hammer, F., Dubois, J., Baselga, E., Brancati, F., Carder, R., Quintal, J. M. C., Dallapiccola, B., Fischer, G., Frieden, I. J., Garzon, M., Harper, J., Johnson-Patel, J., Labrèze, C., Martorell, L., Paltiel, H. J., Pohl, A., Prendiville, J., Quere, I., Siegel, D. H., Valente, E. M., Van Hagen, A., Van Hest, L., Vaux, K. K., Vicente, A., Weibel, L., Chitayat, D., & Vikkula, M.
- Venue
- Human Mutation
- Publisher
- Wiley
- Published
- 2008
- Volume
- 29
- Issue
- 7
- Pages
- 959-965
- ISSN
- 1059-7794 (ISSN-L)
- 1098-1004
- OpenAlex
- W2164903526
- Cited by
- 435
- References
- 15
- FWCI
- 20.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.